NRG2026 Winter NRG Web Hero(1).png

NRG2026 Winter Meeting

Registration for #NRG2026 coming soon!

#NRG2026 Winter Meeting

Search for clinical trials.

Search Publications Search Protocols

A Focus On Science

NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.

 

>
NCI Community Oncology Research Programs NCI National Clinical Trials Program

Uniquely positioned

Internationally recognized investigators populate the leadership and membership of all seven cancer disease site committees encompassed by NRG Oncology.

  • Brain tumors
  • Breast cancer
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Gynecologic cancer
  • Head and Neck cancer
  • Lung cancer
Learn More For Patients
NRG is a platform to find better treatment for cancer of tomorrow.

Ending Cancer

Ending cancer as we know it means commitment to research. Commitment for funding, commitment to participate, and commitment from researchers. Working together makes a difference. Cynthia Licavoli, RN

Ending Cancer

Our Mission

Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research

Dr. Robert S. Mannel

Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.

Membership Resources

NRG Oncology's membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.

Learn More

Latest News

Card image cap
FORTE Study Updates (October 2025)

Read More
Card image cap
NCI RCR and AURORA Integration

Read More
Card image cap
ComboMATCH EAY191-N5 is Accruing Patients with Recurrent or Persistent HER2+ Gynecologic Cancers and Other Solid Tumors

Read More
See All Posts

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are one of the leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.